News AZ's Tagrisso approved for untreated lung cancer in US Tagrisso outperformed first-generation TKI drugs in FLAURA trial
Views & Analysis Bahija Jallal: pharma’s Woman of the Year in a landmark 12 m... AstraZeneca’s Bahija Jallal was named the Healthcare Businesswomen’s Association (HBA) Women of the Year for 2017 – in what turned out to a watershed year for women’s rights.
News AZ's Tagrisso brings 'unprecedented' benefit in untreated NS... Drug could become standard of care, says AZ
News AZ grabs licence as Ionis NASH drug heads to the clinic Could antisense drug be a fatty liver disease blockbuster?
News Pfizer's lung cancer drug dacomitinib gets fast US review Drug beat AZ's Iressa in head-to-head trial, concerns over side-effects
News EU clears first drug therapy for rare disease cALD Neuraxpharm and Minoryx' Nezglyal has become the first approved drug therapy in the EU for rare neurodegenerative disease cALD.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
